Jim Wallace comes from a career in health care, as head of strategy for Anthem, president of AmeriPlus, and chief executive officer of DecisionRx, the pioneering medication therapy optimization company. Prior to his career in health care, Jim was a combat pilot in the U.S. Army and a strategy consultant with Bain & Company. Jim has also worked with the Walt Disney Company, Fox Entertainment, and SpaceX, leading domestic and international business development efforts as senior advisor to the board and CEO.
Jim has a Bachelor of Science degree from the U.S. Military Academy, a Master of Business Administration degree from Harvard Business School, and a Doctor of Business Administration degree from the University of South Florida. Jim’s strategy, capital markets, and business development experience combine with his 30 years of corporate and government relationships to bring a unique combination of knowledge and discipline to organizations he works with.
While current government and commercial efforts to negotiate competitive drug prices are important, this focus represents a minor—and misplaced—implementation of medication management. It’s time that policymakers, insurers and healthcare providers make pharmacogenomic testing a fundamental standard of care delivery.